Company Profiles

driven by the PitchBook Platform

Kiyatec

Description

Developer of technologies designed to usher in a new world of cancer drug response profiling. The company's technologies focus on the provision of vitro diagnostic capabilities for analyzing cell-material interactions and drug discovery, as well as bioreactor products for the future of regenerative medicine and also use living cells grown and tested in a more relevant 3D tumor microenvironment, enabling pharmaceutical, biomedical and life science industries to evaluate, test and deliver innovative cancer therapeutics.

2005

Founded

PRIVATE

Status

11-50

Employees

Series B

Latest Deal Type

$3.15M

Latest Deal Amount

$7.48M

Total Amount Raised

Description

Developer of technologies designed to usher in a new world of cancer drug response profiling. The company's technologies focus on the provision of vitro diagnostic capabilities for analyzing cell-material interactions and drug discovery, as well as bioreactor products for the future of regenerative medicine and also use living cells grown and tested in a more relevant 3D tumor microenvironment, enabling pharmaceutical, biomedical and life science industries to evaluate, test and deliver innovative cancer therapeutics.

Website:

www.kiyatec.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery
Other Healthcare Technology Systems

Primary Office

900-B West Faris Road Greenville, SC 29605United States +1 (864) 502-2013
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Kiyatec's full profile, request a free trial.

Kiyatec Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Kiyatec Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Kiyatec Investors (3)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
NMT CapitalPE/BuyoutMinority000 0000000 0000
SCRA Technology VenturesVenture CapitalMinority000 0000000 0000
Upstate Carolina Angel NetworkAngel GroupMinority000 0000000 0000
NMT Capital PE/Buyout
SCRA Technology Ventures Venture Capital
Upstate Carolina Angel Network Angel Group

Kiyatec Executive Team (4)

NameTitleBoard
Seat
Contact
Info
Matthew Gevaert Ph.DCo-founder, Chief Executive Officer & Board Member
Lillia HolmesChief Operating Officer
Bryce ChaneySenior Director, Business Development
Howland Crosswell MDChief Medical Officer
Matthew Gevaert Ph.D Co-founder, Chief Executive Officer & Board Member
Lillia Holmes Chief Operating Officer
Bryce Chaney Senior Director, Business Development
Howland Crosswell MD Chief Medical Officer

Kiyatec Board Members (6)

NameRepresentingRoleSinceContact
Info
Christopher BrothertonUpstate Carolina Angel NetworkDirector, UCAN Titanium Investment000 0000
Gregory ZaicNMT CapitalPrincipal & General Partner000 0000
Lee Higdon IIISelfBoard Member000 0000
Martin EttlemyerSCRA Technology VenturesDirector, Industry Programs000 0000
Matthew Gevaert Ph.DKiyatecCo-founder, Chief Executive Officer & Board Member000 0000
Christopher Brotherton Director, UCAN Titanium Investment Upstate Carolina Angel Network
Gregory Zaic Principal & General Partner NMT Capital
Lee Higdon III Board Member Self
Martin Ettlemyer Director, Industry Programs SCRA Technology Ventures
Matthew Gevaert Ph.D Co-founder, Chief Executive Officer & Board Member Kiyatec
Request full access to PitchBook